Organisation paid for research Program year 2025 Source: CMS Open Payments

Integrated Medical Professionals

Neither a doctor nor a teaching hospital

Research payments

$1,623,528

67 payments

Through program year 2025, Integrated Medical Professionals is reported as receiving $1,623,528 in research payments, across 67 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$214,350	20
2024	Research	$840,000	25
2023	Research	$303,600	6
2022	Research	$166,375	2
2021	Research	$4,062	2
2020	Research	$26,533	7
2019	Research	$68,608	5

Breakdown

Who paid Research payments · program years 2019–2025

Vanda Pharmaceuticals Inc. $1,337,538 49 payments
Myriad Genetic Laboratories, Inc. $166,375 2 payments
Allergan Inc. $80,339 13 payments
Bayer HealthCare Pharmaceuticals Inc. $20,413 2 payments
Ipsen Innovation $18,863 1 payment

Studies the money was for Research payments · program years 2019–2025

An Open Label Study to Investigate the Safety and Efficacy of Tradipitant in Participants Affected By Motion Sickness $589,175 13 payments
A Study to Investigate the Efficacy of Tradipitant in Subjects Affected By Motion Sickness $533,738 15 payments
EndoPredict Extended Endocrine Trial (EXET) $166,375 2 payments
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness $151,550 14 payments
A Study Evaluating the Efficacy and Safety of BOTOX Intravesical Instillation in Patients with Overactive Bladder and Urinary Incontinence $76,277 11 payments
Tradipitant - Glp-1R Agonist-Induced Nausea and Vomiting $62,800 6 payments
A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis $18,863 1 payment
Research Agreement - Advanced Radiation Centers of New York $14,000 1 payment
DAROL: Darolutamide Observational Study in castration resistant prostate cancer patients $6,413 1 payment
A Study Evaluating the Efficacy and Safety of BOTOX Intravesical Instillation in Patients with Overactive Bladder and Urinary Incontinence $4,062 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.